These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sclerotherapy for treatment of hemangiomas.
    Author: Winter H, Dräger E, Sterry W.
    Journal: Dermatol Surg; 2000 Feb; 26(2):105-8. PubMed ID: 10691936.
    Abstract:
    BACKGROUND: While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown. OBJECTIVE: The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population. METHODS: Over a period of 20 years (1975-1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face. RESULTS: One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long-term results were convincing. Severe complications were not observed. CONCLUSION: Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment.
    [Abstract] [Full Text] [Related] [New Search]